Liver atrophy and portal stenosis in two cases of sclerosing cholangitis associated with autoimmune pancreatitis

Internal Medicine

Volumn 47, Issue 19, 2008, Pages 1689-1694

  Hirano, Atsuyuki ^a   Nakazawa, Takahiro ^b   Ohara, Hirotaka ^b   Ando, Tomoaki ^b   Hayashi, Kazuki ^b   Tanaka, Hajime ^b   Naito, Itaru ^b   Okumura, Fumihiro ^b   Yokoyama, Yoshifumi ^a   Joh, Takashi ^b  

^a Higashi Municipal Hospital   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Autoimmune pancreatitis; Liver atrophy; Prognosis; Sclerosing cholangitis

Indexed keywords

PREDNISOLONE;

AGED; ARTICLE; AUTOIMMUNE PANCREATITIS; BILIARY TRACT DRAINAGE; CASE REPORT; CLINICAL OBSERVATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; JAUNDICE; LABORATORY TEST; LIVER ATROPHY; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MALE; PORTAL VEIN OBSTRUCTION; SCLEROSING CHOLANGITIS; STEROID THERAPY;

ADRENAL CORTEX HORMONES; AGED; ATROPHY; AUTOIMMUNE DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; CONSTRICTION, PATHOLOGIC; FEMALE; HUMANS; LIVER; MALE; PANCREATITIS; PORTAL VEIN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 56349157432     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1192     Document Type: Article

References (25)

1. Yoshida K, Toki F, Takeuchi T, et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40: 1561-1568, 1995.
2. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 51: 1-4, 2002.
3. Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 4: 1010-1016; quiz 934, 2006.
4. Kim KP, Kim MH, Kim JC, et al. Diagnostic criteria for autoimmune chronic pancreatitis revisited. World J Gastroenterol 12: 2487-2496, 2006.
5. Takayama M, Hamano H, Ochi Y, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol 99: 932-937, 2004.
6. Nakazawa T, Ohara H, Yamada T, et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology 48: 625-630, 2001.
7. Nakazawa T, Ohara H, Sano H, et al. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis. Pancreas 30: 20-25, 2005.
8. Nakazawa T, Ohara H, Sano H, et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest Endosc 60: 937-944, 2004.
9. Angulo P, Batts KP, Jorgensen RA, et al. Oral budesonide in the treatment of primary sclerosing cholangitis. Am J Gastroenterol 95: 2333-2337, 2000.
10. van Hoogstraten HJ, Vleggaar FP, Boland GJ, et al. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group. Am J Gastroenterol 95: 2015-2022, 2000.
11. Nakazawa T, Ohara H, Sano H, Ando T, Joh T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas 32: 229, 2006.
12. Members of the criteria committee for autoimmune pancreatitis of the Japan pancreas society. Diagnostic criteria for autoimmune pancreatitis by the Japan pancreas society (in Japanese with English abstract). J Jpn Panc Soc 17: 585-587, 2002.
13. Lee KH, Han JK, Jeong JK, et al. Hepatic attenuation differences associated with obstruction of the portal or hepatic veins in patients with hepatic abscess. AJR Am J Roentgenol 185: 1015-1023, 2005.
14. Mendes FD, Jorgensen R, Keach J, et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am J Gastroenterol 101: 1-6, 2006.
15. Hamano H, Kawa S, Uehara T, et al. Immunoglobulin G4-related lymphoplasmacytic sclerosing cholangitis that mimics infiltrating hilar cholangiocarcinoma: part of a spectrum of autoimmune pancreatitis? Gastrointest Endosc 62: 152-157, 2005.
16. Hayashi K, Nakazawa T, Ohara H, et al. Autoimmune sclerosing cholangiopancreatitis with little pancreatic involvements by imaging findings. Hepato-Gastroenterol 54: 2150-2155, 2007.
17. Nishino T, Toki F, Oyama H, et al. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med 45: 497-501, 2006.
18. Ito T, Nakano I, Koyanagi S, et al. Autoimmune pancreatitis as a new clinical entity. Three cases of autoimmune pancreatitis with effective steroid therapy. Dig Dis Sci 42: 1458-1468, 1997.
19. Ohara H, Nakazawa T, Sano H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 31: 232-237, 2005.
20. Nakazawa T, Ohara H, Ando T, et al. Clinical course and indications for steroid therapy of sclerosing cholangitis associated with autoimmune pancreatitis. Hepato-Gastroenterol (in press).
21. Kamisawa T, Egawa N, Nakajima H, et al. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol 98: 2694-2699, 2003.
22. Sakata N, Tashiro T, Uesugi N, et al. IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am J Surg Pathol 32: 553-559, 2008.
23. Matsumoto Y, Kasashima S, Kawashima A, et al. A case of multiple immunoglobulin G4-related periarteritie: a tumorous lesion of the coronary artery and abdominal aortic aneurysm. Hum Pathol 39: 975-980, 2008.
24. Meyer S, Hausman R. Occlusive phlebitis in multifocal fibrosclerosis. Am J Clin Pathol 65: 274-283, 1976.
25. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 28: 1193-1203, 2004.